APO Research
Talk to an analyst

APO RESEARCH · REPORT

Scopolamine

Scopolamine is a medication used in the treatment of motion sickness and postoperative nausea and vomiting. Scopolamine is used to prevent nausea and vomiting caused by motion sickness or from anesthesia given during surgery.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

Scopolamine is a medication used in the treatment of motion sickness and postoperative nausea and vomiting. Scopolamine is used to prevent nausea and vomiting caused by motion sickness or from anesthesia given during surgery.

Selected research

Market Structure

Global Scopolamine Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

1 January 2026187 pages

Choose your research edition.

Industry ResearchScopolamine Industry Research Report 2026118 pages · $2,950 USDIndustry Growth & TrendsGlobal Scopolamine Industry Growth and Trends Forecast to 203294 pages · $3,450 USDMarket StructureGlobal Scopolamine Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032187 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Scopolamine Market Outlook and Growth Opportunities 2026194 pages · $4,250 USDMarket Analysis & ForecastGlobal Scopolamine Market Analysis and Forecast 2026-2032191 pages · $4,950 USD

Market perspective

Scopolamine is a medication used in the treatment of motion sickness and postoperative nausea and vomiting. Scopolamine is used to prevent nausea and vomiting caused by motion sickness or from anesthesia given during surgery.

The major players in global Scopolamine market include Alkaloids of Australia, Boehringer Ingelheim, Fine Chemicals Corporation, etc. The top 3 players occupy about 55% shares of the global market. Australia and Europe are main markets, they occupy about 60% of the global market. Scopolamine Hydrobromide is the main type, with a share about 45%. Patches is the main application, which holds a share about 60%.

This report provides an overview of the global Scopolamine market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

Read the full market overview

The study covers key producers of Scopolamine and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Scopolamine sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Scopolamine market size, projected growth trends, production technologies, key applications, and end-use industries.

Scopolamine Segment by Company

Alkaloids of Australia

Boehringer Ingelheim

Fine Chemicals Corporation

Phytex Australia

Alchem International

Guangzhou Hanfang

Alkaloids Corporation

Luyin

Scopolamine Segment by Type

Scopolamine Butylbromide

Scopolamine Hydrobromide

Others

Scopolamine Segment by Application

Tablets

Injection

Patches

Scopolamine Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Scopolamine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Scopolamine and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Scopolamine.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Scopolamine market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Scopolamine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Scopolamine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Scopolamine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Scopolamine Industry Trends Table 2. Scopolamine Industry Drivers Table 3. Scopolamine Industry Opportunities and Challenges Table 4. Scopolamine Industry Restraints Table 5. Global Scopolamine Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Scopolamine Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Scopolamine Sales by Manufacturers (Kg) & (2021-2026) Table 8. Global Scopolamine Sales Market Share by Manufacturers Table 9. Global Scopolamine Average Sales Price (US$/Kg) of Manufacturers (2021-2026) Table 10. Global Scopolamine Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Scopolamine Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Scopolamine Manufacturers, Product Type & Application Table 13. Global Scopolamine Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Scopolamine by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Scopolamine Butylbromide Table 17. Major Manufacturers of Scopolamine Hydrobromide Table 18. Major Manufacturers of Others Table 19. Global Scopolamine Sales by Type 2021 VS 2025 VS 2032 (Kg) Table 20. Global Scopolamine Sales by Type (2021-2026) & (Kg) Table 21. Global Scopolamine Sales by Type (2027-2032) & (Kg) Table 22. Global Scopolamine Sales Market Share by Type (2021-2026) Table 23. Global Scopolamine Sales Market Share by Type (2027-2032) Table 24. Global Scopolamine Revenue by Type 2021 VS 2025 VS 2032 (Kg) Table 25. Global Scopolamine Revenue by Type (2021-2026) & (Kg) Table 26. Global Scopolamine Revenue by Type (2027-2032) & (Kg) Table 27. Global Scopolamine Revenue Market Share by Type (2021-2026) Table 28. Global Scopolamine Revenue Market Share by Type (2027-2032) Table 29. Major Manufacturers of Tablets Table 30. Major Manufacturers of Injection Table 31. Major Manufacturers of Patches Table 32. Global Scopolamine Sales by Application 2021 VS 2025 VS 2032 (Kg) Table 33. Global Scopolamine Sales by Application (2021-2026) & (Kg) Table 34. Global Scopolamine Sales by Application (2027-2032) & (Kg) Table 35. Global Scopolamine Sales Market Share by Application (2021-2026) Table 36. Global Scopolamine Sales Market Share by Application (2027-2032) Table 37. Global Scopolamine Revenue by Application 2021 VS 2025 VS 2032 (Kg) Table 38. Global Scopolamine Revenue by Application (2021-2026) & (Kg) Table 39. Global Scopolamine Revenue by Application (2027-2032) & (Kg) Table 40. Global Scopolamine Revenue Market Share by Application (2021-2026) Table 41. Global Scopolamine Revenue Market Share by Application (2027-2032) Table 42. Global Scopolamine Sales by Region: 2021 VS 2025 VS 2032 (Kg) Table 43. Global Scopolamine Sales by Region (2021-2026) & (Kg) Table 44. Global Scopolamine Sales Market Share by Region (2021-2026) Table 45. Global Scopolamine Sales Forecasted by Region (2027-2032) & (Kg) Table 46. Global Scopolamine Sales Forecasted Market Share by Region (2027-2032) Table 47. North America Scopolamine Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (Kg) Table 48. North America Scopolamine Sales by Country (2021-2026) & (Kg) Table 49. North America Scopolamine Sales by Country (2027-2032) & (Kg) Table 50. Europe Scopolamine Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (Kg) Table 51. Europe Scopolamine Sales by Country (2021-2026) & (Kg) Table 52. Europe Scopolamine Sales by Country (2027-2032) & (Kg) Table 53. Asia Pacific Scopolamine Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (Kg) Table 54. Asia Pacific Scopolamine Sales by Country (2021-2026) & (Kg) Table 55. Asia Pacific Scopolamine Sales by Country (2027-2032) & (Kg) Table 56. South America, Middle East and Africa Scopolamine Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (Kg) Table 57. South America, Middle East and Africa Scopolamine Sales by Country (2021-2026) & (Kg) Table 58. South America, Middle East and Africa Scopolamine Sales by Country (2027-2032) & (Kg) Table 59. Global Scopolamine Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 60. Global Scopolamine Revenue by Region (2021-2026) & (US$ Million) Table 61. Global Scopolamine Revenue by Region (2027-2032) & (US$ Million) Table 62. Global Scopolamine Revenue Market Share by Region (2021-2026) Table 63. Global Scopolamine Revenue Market Share by Region (2027-2032) Table 64. Alkaloids of Australia Company Information Table 65. Alkaloids of Australia Business Overview Table 66. Alkaloids of Australia Scopolamine Sales (Kg), Price (US$/Kg), Revenue (US$ Million) and Gross Margin (2021-2026) Table 67. Alkaloids of Australia Scopolamine Product Portfolio Table 68. Alkaloids of Australia Recent Development Table 69. Boehringer Ingelheim Company Information Table 70. Boehringer Ingelheim Business Overview Table 71. Boehringer Ingelheim Scopolamine Sales (Kg), Price (US$/Kg), Revenue (US$ Million) and Gross Margin (2021-2026) Table 72. Boehringer Ingelheim Scopolamine Product Portfolio Table 73. Boehringer Ingelheim Recent Development Table 74. Fine Chemicals Corporation Company Information Table 75. Fine Chemicals Corporation Business Overview Table 76. Fine Chemicals Corporation Scopolamine Sales (Kg), Price (US$/Kg), Revenue (US$ Million) and Gross Margin (2021-2026) Table 77. Fine Chemicals Corporation Scopolamine Product Portfolio Table 78. Fine Chemicals Corporation Recent Development Table 79. Phytex Australia Company Information Table 80. Phytex Australia Business Overview Table 81. Phytex Australia Scopolamine Sales (Kg), Price (US$/Kg), Revenue (US$ Million) and Gross Margin (2021-2026) Table 82. Phytex Australia Scopolamine Product Portfolio Table 83. Phytex Australia Recent Development Table 84. Alchem International Company Information Table 85. Alchem International Business Overview Table 86. Alchem International Scopolamine Sales (Kg), Price (US$/Kg), Revenue (US$ Million) and Gross Margin (2021-2026) Table 87. Alchem International Scopolamine Product Portfolio Table 88. Alchem International Recent Development Table 89. Guangzhou Hanfang Company Information Table 90. Guangzhou Hanfang Business Overview Table 91. Guangzhou Hanfang Scopolamine Sales (Kg), Price (US$/Kg), Revenue (US$ Million) and Gross Margin (2021-2026) Table 92. Guangzhou Hanfang Scopolamine Product Portfolio Table 93. Guangzhou Hanfang Recent Development Table 94. Alkaloids Corporation Company Information Table 95. Alkaloids Corporation Business Overview Table 96. Alkaloids Corporation Scopolamine Sales (Kg), Price (US$/Kg), Revenue (US$ Million) and Gross Margin (2021-2026) Table 97. Alkaloids Corporation Scopolamine Product Portfolio Table 98. Alkaloids Corporation Recent Development Table 99. Luyin Company Information Table 100. Luyin Business Overview Table 101. Luyin Scopolamine Sales (Kg), Price (US$/Kg), Revenue (US$ Million) and Gross Margin (2021-2026) Table 102. Luyin Scopolamine Product Portfolio Table 103. Luyin Recent Development Table 104. Key Raw Materials Table 105. Raw Materials Key Suppliers Table 106. Scopolamine Distributors List Table 107. Scopolamine Customers List Table 108. Research Programs/Design for This Report Table 109. Authors List of This Report Table 110. Secondary Sources Table 111. Primary Sources List of Figures Figure 1. Scopolamine Product Image Figure 2. Global Scopolamine Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Scopolamine Market Size (2021-2032) & (US$ Million) Figure 4. Global Scopolamine Sales (2021-2032) & (Kg) Figure 5. Global Scopolamine Average Price (US$/Kg) & (2021-2032) Figure 6. Global Top 5 and 10 Scopolamine Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Scopolamine Butylbromide Image Figure 9. Scopolamine Hydrobromide Image Figure 10. Others Image Figure 11. Global Scopolamine Sales by Type (2021 VS 2025 VS 2032) & (Kg) Figure 12. Global Scopolamine Sales Market Share 2021 VS 2025 VS 2032 Figure 13. Global Scopolamine Sales Market Share by Type (2021-2032) Figure 14. Global Scopolamine Revenue by Type (2021 VS 2025 VS 2032) & (Kg) Figure 15. Global Scopolamine Revenue Market Share 2021 VS 2025 VS 2032 Figure 16. Global Scopolamine Revenue Market Share by Type (2021-2032) Figure 17. Tablets Image Figure 18. Injection Image Figure 19. Patches Image Figure 20. Global Scopolamine Sales by Application (2021 VS 2025 VS 2032) & (Kg) Figure 21. Global Scopolamine Sales Market Share 2021 VS 2025 VS 2032 Figure 22. Global Scopolamine Sales Market Share by Application (2021-2032) Figure 23. Global Scopolamine Revenue by Application (2021 VS 2025 VS 2032) & (Kg) Figure 24. Global Scopolamine Revenue Market Share 2021 VS 2025 VS 2032 Figure 25. Global Scopolamine Revenue Market Share by Application (2021-2032) Figure 26. North America Scopolamine Sales and Growth Rate (2021-2032) & (Kg) Figure 27. North America Scopolamine Sales Market Share by Country (2021-2032) Figure 28. U.S. Scopolamine Sales and Growth Rate (2021-2032) & (Kg) Figure 29. Canada Scopolamine Sales and Growth Rate (2021-2032) & (Kg) Figure 30. Mexico Scopolamine Sales and Growth Rate (2021-2032) & (Kg) Figure 31. Europe Scopolamine Sales and Growth Rate (2021-2032) & (Kg) Figure 32. Europe Scopolamine Sales Market Share by Country (2021-2032) Figure 33. Germany Scopolamine Sales and Growth Rate (2021-2032) & (Kg) Figure 34. France Scopolamine Sales and Growth Rate (2021-2032) & (Kg) Figure 35. U.K. Scopolamine Sales and Growth Rate (2021-2032) & (Kg) Figure 36. Italy Scopolamine Sales and Growth Rate (2021-2032) & (Kg) Figure 37. Netherlands Scopolamine Sales and Growth Rate (2021-2032) & (Kg) Figure 38. Asia Pacific Scopolamine Sales and Growth Rate (2021-2032) & (Kg) Figure 39. Asia Pacific Scopolamine Sales Market Share by Country (2021-2032) Figure 40. China Scopolamine Sales and Growth Rate (2021-2032) & (Kg) Figure 41. Japan Scopolamine Sales and Growth Rate (2021-2032) & (Kg) Figure 42. South Korea Scopolamine Sales and Growth Rate (2021-2032) & (Kg) Figure 43. Southeast Asia Scopolamine Sales and Growth Rate (2021-2032) & (Kg) Figure 44. India Scopolamine Sales and Growth Rate (2021-2032) & (Kg) Figure 45. Australia Scopolamine Sales and Growth Rate (2021-2032) & (Kg) Figure 46. South America, Middle East and Africa Scopolamine Sales and Growth Rate (2021-2032) & (Kg) Figure 47. South America, Middle East and Africa Scopolamine Sales Market Share by Country (2021-2032) Figure 48. Brazil Scopolamine Sales and Growth Rate (2021-2032) & (Kg) Figure 49. South Africa Scopolamine Sales and Growth Rate (2021-2032) & (Kg) Figure 50. Saudi Arabia Scopolamine Sales and Growth Rate (2021-2032) & (Kg) Figure 51. Turkey Scopolamine Sales and Growth Rate (2021-2032) & (Kg) Figure 52. Argentina Scopolamine Sales and Growth Rate (2021-2032) & (Kg) Figure 53. UAE Scopolamine Sales and Growth Rate (2021-2032) & (Kg) Figure 54. Egypt Scopolamine Sales and Growth Rate (2021-2032) & (Kg) Figure 55. Chile Scopolamine Sales and Growth Rate (2021-2032) & (Kg) Figure 56. Global Scopolamine Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 57. Global Scopolamine Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 58. North America Scopolamine Revenue (2021-2032) & (US$ Million) Figure 59. North America Scopolamine Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 60. Europe Scopolamine Revenue (2021-2032) & (US$ Million) Figure 61. Europe Scopolamine Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 62. Asia-Pacific Scopolamine Revenue (2021-2032) & (US$ Million) Figure 63. Asia-Pacific Scopolamine Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 64. South America, Middle East and Africa Scopolamine Revenue (2021-2032) & (US$ Million) Figure 65. South America, Middle East and Africa Scopolamine Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 66. Scopolamine Value Chain Figure 67. Manufacturing Cost Structure Figure 68. Scopolamine Production Mode & Process Figure 69. Direct Comparison with Distribution Share Figure 70. Distributors Profiles Figure 71. Years Considered Figure 72. Research Process Figure 73. Key Executives Interviewed

Scope & coverage.

Types
  • Scopolamine Butylbromide
  • Scopolamine Hydrobromide
  • Others
Applications
  • Tablets
  • Injection
  • Patches
Companies covered
  • Alkaloids of Australia
  • Boehringer Ingelheim
  • Fine Chemicals Corporation
  • Phytex Australia
  • Alchem International
  • Guangzhou Hanfang
  • Alkaloids Corporation
  • Luyin

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Scopolamine Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Scopolamine Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Scopolamine Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Scopolamine Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Scopolamine Market Dynamics
  1. 2.1 Scopolamine Industry Trends
  2. 2.2 Scopolamine Industry Drivers
  3. 2.3 Scopolamine Industry Opportunities and Challenges
  4. 2.4 Scopolamine Industry Restraints
3 Scopolamine Market by Manufacturers
  1. 3.1 Global Scopolamine Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Scopolamine Sales by Manufacturers (2021-2026)
  3. 3.3 Global Scopolamine Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Scopolamine Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Scopolamine Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Scopolamine Manufacturers, Product Type & Application
  7. 3.7 Global Scopolamine Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Scopolamine Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Scopolamine Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Scopolamine Tier 1, Tier 2, and Tier 3
4 Scopolamine Market by Type
  1. 4.1 Scopolamine Type Introduction
  2. 4.1.1 Scopolamine Butylbromide
  3. 4.1.2 Scopolamine Hydrobromide
  4. 4.1.3 Others
  5. 4.2 Global Scopolamine Sales by Type
  6. 4.2.1 Global Scopolamine Sales by Type (2021 VS 2025 VS 2032)
  7. 4.2.2 Global Scopolamine Sales by Type (2021-2032)
  8. 4.2.3 Global Scopolamine Sales Market Share by Type (2021-2032)
  9. 4.3 Global Scopolamine Revenue by Type
  10. 4.3.1 Global Scopolamine Revenue by Type (2021 VS 2025 VS 2032)
  11. 4.3.2 Global Scopolamine Revenue by Type (2021-2032)
  12. 4.3.3 Global Scopolamine Revenue Market Share by Type (2021-2032)
5 Scopolamine Market by Application
  1. 5.1 Scopolamine Application Introduction
  2. 5.1.1 Tablets
  3. 5.1.2 Injection
  4. 5.1.3 Patches
  5. 5.2 Global Scopolamine Sales by Application
  6. 5.2.1 Global Scopolamine Sales by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Scopolamine Sales by Application (2021-2032)
  8. 5.2.3 Global Scopolamine Sales Market Share by Application (2021-2032)
  9. 5.3 Global Scopolamine Revenue by Application
  10. 5.3.1 Global Scopolamine Revenue by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Scopolamine Revenue by Application (2021-2032)
  12. 5.3.3 Global Scopolamine Revenue Market Share by Application (2021-2032)
6 Global Scopolamine Sales by Region
  1. 6.1 Global Scopolamine Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Scopolamine Sales by Region (2021-2032)
  3. 6.2.1 Global Scopolamine Sales by Region (2021-2026)
  4. 6.2.2 Global Scopolamine Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Scopolamine Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Scopolamine Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Scopolamine Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Scopolamine Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Scopolamine Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Scopolamine Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Scopolamine Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Scopolamine Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Scopolamine Revenue by Region
  1. 7.1 Global Scopolamine Revenue by Region
  2. 7.1.1 Global Scopolamine Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Scopolamine Revenue by Region (2021-2026)
  4. 7.1.3 Global Scopolamine Revenue by Region (2027-2032)
  5. 7.1.4 Global Scopolamine Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Scopolamine Revenue (2021-2032)
  8. 7.2.2 North America Scopolamine Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Scopolamine Revenue (2021-2032)
  11. 7.3.2 Europe Scopolamine Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Scopolamine Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Scopolamine Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Scopolamine Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Scopolamine Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Alkaloids of Australia
  2. 8.1.1 Alkaloids of Australia Company Information
  3. 8.1.2 Alkaloids of Australia Business Overview
  4. 8.1.3 Alkaloids of Australia Scopolamine Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Alkaloids of Australia Scopolamine Product Portfolio
  6. 8.1.5 Alkaloids of Australia Recent Developments
  7. 8.2 Boehringer Ingelheim
  8. 8.2.1 Boehringer Ingelheim Company Information
  9. 8.2.2 Boehringer Ingelheim Business Overview
  10. 8.2.3 Boehringer Ingelheim Scopolamine Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Boehringer Ingelheim Scopolamine Product Portfolio
  12. 8.2.5 Boehringer Ingelheim Recent Developments
  13. 8.3 Fine Chemicals Corporation
  14. 8.3.1 Fine Chemicals Corporation Company Information
  15. 8.3.2 Fine Chemicals Corporation Business Overview
  16. 8.3.3 Fine Chemicals Corporation Scopolamine Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Fine Chemicals Corporation Scopolamine Product Portfolio
  18. 8.3.5 Fine Chemicals Corporation Recent Developments
  19. 8.4 Phytex Australia
  20. 8.4.1 Phytex Australia Company Information
  21. 8.4.2 Phytex Australia Business Overview
  22. 8.4.3 Phytex Australia Scopolamine Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Phytex Australia Scopolamine Product Portfolio
  24. 8.4.5 Phytex Australia Recent Developments
  25. 8.5 Alchem International
  26. 8.5.1 Alchem International Company Information
  27. 8.5.2 Alchem International Business Overview
  28. 8.5.3 Alchem International Scopolamine Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Alchem International Scopolamine Product Portfolio
  30. 8.5.5 Alchem International Recent Developments
  31. 8.6 Guangzhou Hanfang
  32. 8.6.1 Guangzhou Hanfang Company Information
  33. 8.6.2 Guangzhou Hanfang Business Overview
  34. 8.6.3 Guangzhou Hanfang Scopolamine Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Guangzhou Hanfang Scopolamine Product Portfolio
  36. 8.6.5 Guangzhou Hanfang Recent Developments
  37. 8.7 Alkaloids Corporation
  38. 8.7.1 Alkaloids Corporation Company Information
  39. 8.7.2 Alkaloids Corporation Business Overview
  40. 8.7.3 Alkaloids Corporation Scopolamine Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Alkaloids Corporation Scopolamine Product Portfolio
  42. 8.7.5 Alkaloids Corporation Recent Developments
  43. 8.8 Luyin
  44. 8.8.1 Luyin Company Information
  45. 8.8.2 Luyin Business Overview
  46. 8.8.3 Luyin Scopolamine Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Luyin Scopolamine Product Portfolio
  48. 8.8.5 Luyin Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Scopolamine Value Chain Analysis
  2. 9.1.1 Scopolamine Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Scopolamine Production Mode & Process
  6. 9.2 Scopolamine Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Scopolamine Distributors
  9. 9.2.3 Scopolamine Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst